The risk variant of rs11672691 in lncRNA PCAT19 suppresses binding of transcription factor NKX3.1 to the promoter of PCAT19-short, resulting in PCAT19-long activation and prostate cancer growth and metastasis (Hua et al., 2018). This evidence concerns the gene NKX3-1 and prostate carcinoma.